vs
Rhinebeck Bancorp, Inc.（RBKB）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
Rhinebeck Bancorp, Inc.的季度营收约是SUTRO BIOPHARMA, INC.的1.2倍（$13.5M vs $11.6M），Rhinebeck Bancorp, Inc.同比增速更快（1701.1% vs -21.4%），过去两年Rhinebeck Bancorp, Inc.的营收复合增速更高（14.0% vs -5.4%）
Rhinebeck Bancorp, Inc.是总部位于美国纽约的区域性银行控股企业，旗下运营莱茵贝克银行，主要面向纽约哈德逊谷地区的个人消费者与中小企业提供储蓄、贷款、抵押贷款、财富管理等零售及商业金融服务。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
RBKB vs STRO — 直观对比
营收规模更大
RBKB
是对方的1.2倍
$11.6M
营收增速更快
RBKB
高出1722.4%
-21.4%
两年增速更快
RBKB
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $11.6M |
| 净利润 | $2.3M | — |
| 毛利率 | — | — |
| 营业利润率 | 21.7% | — |
| 净利率 | 17.3% | — |
| 营收同比 | 1701.1% | -21.4% |
| 净利润同比 | 188.0% | 35.4% |
| 每股收益（稀释后） | $0.21 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RBKBSTRO
| Q4 25 | $13.5M | $11.6M | ||
| Q3 25 | $14.0M | $9.7M | ||
| Q2 25 | $13.1M | $63.7M | ||
| Q1 25 | $12.8M | $17.4M | ||
| Q4 24 | $750.0K | $14.8M | ||
| Q3 24 | $773.0K | $8.5M | ||
| Q2 24 | $10.7M | $25.7M | ||
| Q1 24 | $10.4M | $13.0M |
净利润RBKBSTRO
| Q4 25 | $2.3M | — | ||
| Q3 25 | $2.7M | $-56.9M | ||
| Q2 25 | $2.7M | $-11.5M | ||
| Q1 25 | $2.3M | $-76.0M | ||
| Q4 24 | $-2.7M | $-72.4M | ||
| Q3 24 | $-8.1M | $-48.8M | ||
| Q2 24 | $975.0K | $-48.0M | ||
| Q1 24 | $1.1M | $-58.2M |
营业利润率RBKBSTRO
| Q4 25 | 21.7% | — | ||
| Q3 25 | 23.9% | -499.9% | ||
| Q2 25 | 26.6% | -5.2% | ||
| Q1 25 | 22.9% | -393.8% | ||
| Q4 24 | -444.9% | -440.7% | ||
| Q3 24 | -1332.3% | -797.2% | ||
| Q2 24 | 11.8% | -189.4% | ||
| Q1 24 | 13.9% | -435.0% |
净利率RBKBSTRO
| Q4 25 | 17.3% | — | ||
| Q3 25 | 19.3% | -586.6% | ||
| Q2 25 | 20.8% | -18.0% | ||
| Q1 25 | 17.9% | -436.6% | ||
| Q4 24 | -353.9% | -489.2% | ||
| Q3 24 | -1042.9% | -572.6% | ||
| Q2 24 | 9.2% | -186.8% | ||
| Q1 24 | 10.8% | -447.5% |
每股收益（稀释后）RBKBSTRO
| Q4 25 | $0.21 | — | ||
| Q3 25 | $0.25 | $-0.67 | ||
| Q2 25 | $0.25 | $-0.14 | ||
| Q1 25 | $0.21 | $-0.91 | ||
| Q4 24 | $-0.24 | $-27.63 | ||
| Q3 24 | $-0.75 | $-0.59 | ||
| Q2 24 | $0.09 | $-0.59 | ||
| Q1 24 | $0.10 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $136.9M | $-132.5M |
| 总资产 | $1.3B | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RBKBSTRO
| Q4 25 | — | $141.4M | ||
| Q3 25 | — | $167.6M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $249.0M | ||
| Q4 24 | — | $316.9M | ||
| Q3 24 | — | $388.3M | ||
| Q2 24 | — | $375.6M | ||
| Q1 24 | — | $267.6M |
股东权益RBKBSTRO
| Q4 25 | $136.9M | $-132.5M | ||
| Q3 25 | $133.0M | $-87.3M | ||
| Q2 25 | $129.0M | $-32.1M | ||
| Q1 25 | $126.0M | $-25.8M | ||
| Q4 24 | $121.8M | $44.6M | ||
| Q3 24 | $122.7M | $111.2M | ||
| Q2 24 | $116.2M | $152.2M | ||
| Q1 24 | $114.3M | $98.0M |
总资产RBKBSTRO
| Q4 25 | $1.3B | $173.8M | ||
| Q3 25 | $1.3B | $209.7M | ||
| Q2 25 | $1.3B | $262.4M | ||
| Q1 25 | $1.3B | $321.4M | ||
| Q4 24 | $1.3B | $387.2M | ||
| Q3 24 | $1.3B | $451.8M | ||
| Q2 24 | $1.3B | $489.0M | ||
| Q1 24 | $1.3B | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.7M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $10.9M | — |
| 自由现金流率自由现金流/营收 | 80.6% | — |
| 资本支出强度资本支出/营收 | 6.3% | — |
| 现金转化率经营现金流/净利润 | 5.03× | — |
| 过去12个月自由现金流最近4个季度 | $19.4M | — |
8季度趋势，按日历期对齐
经营现金流RBKBSTRO
| Q4 25 | $11.7M | $-177.2M | ||
| Q3 25 | $2.2M | $-38.2M | ||
| Q2 25 | $2.4M | $-44.7M | ||
| Q1 25 | $4.3M | $-67.9M | ||
| Q4 24 | $8.5M | $-71.7M | ||
| Q3 24 | $-3.6M | $-64.5M | ||
| Q2 24 | $12.0M | $9.5M | ||
| Q1 24 | $-3.5M | $-64.7M |
自由现金流RBKBSTRO
| Q4 25 | $10.9M | — | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $7.7M | — | ||
| Q3 24 | $-3.6M | — | ||
| Q2 24 | $11.8M | — | ||
| Q1 24 | $-3.7M | — |
自由现金流率RBKBSTRO
| Q4 25 | 80.6% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 17.2% | — | ||
| Q1 25 | 32.8% | — | ||
| Q4 24 | 1023.9% | — | ||
| Q3 24 | -469.0% | — | ||
| Q2 24 | 111.1% | — | ||
| Q1 24 | -36.0% | — |
资本支出强度RBKBSTRO
| Q4 25 | 6.3% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 105.5% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 2.3% | — |
现金转化率RBKBSTRO
| Q4 25 | 5.03× | — | ||
| Q3 25 | 0.83× | — | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | 1.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 12.27× | — | ||
| Q1 24 | -3.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
